J 2023

The Endocannabinoid System - The Prediction of Spontaneous Preterm Birth in High-Risk Women: Protocol of a Study

PARIZEK, Antonin, Martin HILL, Michaela DUSKOVA, Lucie KOLATOROVA, Josef SUCHOPAR et. al.

Základní údaje

Originální název

The Endocannabinoid System - The Prediction of Spontaneous Preterm Birth in High-Risk Women: Protocol of a Study

Autoři

PARIZEK, Antonin (203 Česká republika), Martin HILL (203 Česká republika), Michaela DUSKOVA (203 Česká republika), Lucie KOLATOROVA (203 Česká republika), Josef SUCHOPAR (203 Česká republika), Patrik SIMJAK (203 Česká republika), Katerina ANDERLOVA (203 Česká republika), Eva KUDOVA (203 Česká republika), Vladimir ROGALEWICZ (203 Česká republika), Jaroslav VACEK (203 Česká republika), Marcela KOUDELKOVÁ (203 Česká republika, domácí), Renata CHLOUPKOVÁ (203 Česká republika, domácí), Miroslava ALBLOVA (203 Česká republika), Petra PARIZKOVA (203 Česká republika), Zdenek LASTUVKA (203 Česká republika) a Miroslav BARTAK (203 Česká republika, garant)

Vydání

Physiological research, Praha, Institute of Physiology of the Czechoslovak Academy of Sciences, 2023, 0862-8408

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30105 Physiology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.100 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133344

Organizační jednotka

Lékařská fakulta

UT WoS

001127421100002

Klíčová slova anglicky

Anandamide (AEA); Endocannabinoids; Endocannabinoid system; 2-arachidonoylglycerol (2-AG); 2-linoleoylglycerol (2-LG); 2-oleoylglycerol (2-OG); 2-arachidonoyldopamine (2-ADOPA center dot NADA); Predicting preterm birth; Spontaneous preterm birth (sPTB)

Štítky

Změněno: 21. 3. 2024 14:44, Mgr. Tereza Miškechová

Anotace

V originále

Spontaneous preterm birth (sPTB) is a major cause of perinatal morbidity and mortality, even in developed countries. Prediction of sPTB is therefore a valuable tool to reduce the associated risks. The current standard for the prediction of sPTB consists, in addition to anamnestic data, of previous sPTB and previous second trimester miscarriage, measurement of cervical length by transvaginal ultrasound (TVU CL) together with assessment of fetal fibronectin levels in cervicovaginal fluid. Other evaluation parameters, such as the level of endocannabinoids in the pregnant woman's blood, could increase the sensitivity of this management. Endocannabinoids (eCBs) are a part of the endocannabinoid system (ECS); out of them anandamide (arachidonoyl-ethanolamide, AEA), in particular, plays an important role in the regulation of pregnancy and childbirth. We present the protocol for an open, non-randomized study to evaluate concentrations of AEA and other endocannabinoids: 2-linoleoylglycerol (2-AG), 2-linoleoylglycerol (2-LG), 2-oleoylgly-cerol (2-OG), and 2-arachidonoyldopamine (2-ADOPA or also NADA) in the blood of pregnant women as potential predictors of sPTB. In a total of 230 women with a history of sPTB or miscarriage, eCBs levels between 22 and 28 weeks of gestation will be assessed from maternal blood, in addition to the standard procedure. The aim of the study is to determine the relationship between blood concentrations of the endocanna-binoids tested and the risk of sPTB. The results of this study will describe the prognostic significance of maternal blood eCBs levels for sPTB, and could subsequently enable improved screening programs for early identification of sPTB.